Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M105,049Revenue (TTM) $M36,959Net Margin (%)0.1Altman Z-Score1.2
Enterprise Value $M130,315EPS (TTM) $0.0Operating Margin %5.3Piotroski F-Score5
P/E(ttm)--Beneish M-Score-2.6Pre-tax Margin (%)2.8Higher ROA y-yN
Price/Book13910-y EBITDA Growth Rate %0.5Quick Ratio0.6Cash flow > EarningsY
Price/Sales3.25-y EBITDA Growth Rate %-5.1Current Ratio0.9Lower Leverage y-yY
Price/Free Cash Flow53.5y-y EBITDA Growth Rate %-78.8ROA % (ttm)0.1Higher Current Ratio y-yN
Dividend Yield %5.1PEG--ROE % (ttm)0.8Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M4,872ROIC % (ttm)4.6Gross Margin Increase y-yN

Gurus Latest Trades with GLAXF

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

GLAXF is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!

GLAXF: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GLAXOSMITHKLINE PLCFormer 10% Owner 2015-02-23Sell503,150$22-2view
GLAXOSMITHKLINE PLC10% Owner 2014-12-18Sell50,000$21.141.99view
GLAXOSMITHKLINE PLCFormer 10% Owner (1) 2014-10-27Sell11,315,825$5.29307.56view
GLAXOSMITHKLINE PLC10% Owner 2014-04-01Buy103,762$1279.67view
GLAXOSMITHKLINE PLCFormer 10% Owner 2014-02-19Buy35,000$1454view
GLAXOSMITHKLINE PLCFormer 10% Shareholder 2014-02-10Buy143,773$1279.67view

Quarterly/Annual Reports about GLAXF:

    News about GLAXF:

    Articles On GuruFocus.com
    Can Novartis Tide Over the Alcon Crisis? Aug 26 2016 
    GlaxoSmithKline's Dividend Health Aug 09 2016 
    Tweedy Browne 2nd Quarter Shareholder Letter Aug 01 2016 
    GlaxoSmithKline’s Sideways Dance May Pay Off in the Long Run Jul 22 2016 
    Why Berkshire Hathaway Dumped Johnson & Johnson Jul 19 2016 
    Andreas Halvorsen's Viking Global Gets Control of Stakes in 2 Companies for Backing Hot Biotech Jul 14 2016 
    Investing in Big Pharma: Pointers on Pfizer Jul 14 2016 
    Getting to Know VBI Vaccines Jul 13 2016 
    Jeff Auxier Sells Precision Castparts, AT&T, Microsoft Jun 23 2016 
    Steven Cohen Adds to Stake in Pernix Therapeutics Jun 07 2016 

    More From Other Websites
    7 Healthcare Dividend Stocks for Quality and Security Aug 26 2016
    How safe is GlaxoSmithKline plc’s dividend? Aug 26 2016
    Top Research Reports for August 25, 2016 Aug 25 2016
    Waiting For Growth, Or A Better Valuation, Argus Stays Sidelined On Novartis Shares Aug 24 2016
    Is Hikma Pharmaceuticals plc the best FTSE 100 healthcare stock to own after today’s update? Aug 24 2016
    Which of these Neil Woodford dividend stocks should you buy today? Aug 23 2016
    Are these 3 top stocks still mighty income machines? Aug 22 2016
    3 blue chip bargains you can’t afford to miss! Aug 22 2016
    Now is the perfect time to buy these 3 healthcare stocks! Aug 19 2016
    Glaxo/Pfizer ViiV Healthcare Starts HIV Drug Combo Study Aug 17 2016
    Is it time to take profits on GlaxoSmithKline plc and AstraZeneca plc? Aug 16 2016
    [$$] FTSE directors turn net sellers of their companies' shares Aug 14 2016
    [$$] Yield to temptation as bond incomes fall Aug 11 2016
    Is this stock the best buy in its sector following today’s update? Aug 10 2016
    GlaxoSmithKline's Dividend Health Aug 09 2016
    What can Google do that GlaxoSmithKline plc cannot? Aug 09 2016
    Jefferies Keeps Red-Hot Dividend Pharmaceutical Stock as Top Sector Pick Aug 05 2016
    Google’s parent company wants to treat disease by zapping you with electricity Aug 03 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)